FDA Aims To Improve Product Risk Communication Under Strategic Plan
This article was originally published in The Gray Sheet
Executive Summary
Under a plan unveiled Sept. 30, FDA aims to increase its understanding of appropriate ways to communicate with the public about product risks and to streamline its product risk communication processes
You may also be interested in...
Risk Communication Plan On Track, FDA Staffer Reports
About a year into the implementation of FDA's risk communication plan, the agency has met most of its 2010 goals, such as publishing a risk communication research agenda, designing surveys about public understanding and improving procedures to test communications more quickly.
Risk Communication Plan On Track, FDA Staffer Reports
About a year into the implementation of FDA's risk communication plan, the agency has met most of its 2010 goals, such as publishing a risk communication research agenda, designing surveys about public understanding and improving procedures to test communications more quickly.
FDA Risk Communication Plan May Be Released Within A Month
FDA's strategic plan for ensuring the public receives accurate and balanced information about the risks and benefits of medical products could be released within a month, according to FDA Center for Drug Evaluation and Research Director Janet Woodcock